Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
291 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Ctca at Western Regional Medical Center
Goodyear, Arizona, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Carti Cancer Center
Little Rock, Arkansas, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Mercy Cancer Center - Carmichael
Carmichael, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- Mercy Cancer Center - Elk Grove
Elk Grove, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Mercy Cancer Center
Merced, California, United States
- Mercy Cancer Center - Rocklin
Rocklin, California, United States
- Mercy Cancer Center - Sacramento
Sacramento, California, United States
- Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, United States
- Mission Hope Medical Oncology - Santa Maria
Santa Maria, California, United States
- Bass Medical Group - Lennon
Walnut Creek, California, United States
- Woodland Memorial Hospital
Woodland, California, United States
- Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, United States
- Boulder Community Foothills Hospital
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers - Centennial
Centennial, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Saint Francis Cancer Center
Colorado Springs, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Rose
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- the Women'S Imaging Center
Denver, Colorado, United States
- Mercy Medical Center
Durango, Colorado, United States
- Southwest Oncology Pc
Durango, Colorado, United States
- Mountain Blue Cancer Care Center - Swedish
Englewood, Colorado, United States
- Rocky Mountain Cancer Centers - Swedish
Englewood, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- the Melanoma and Skin Cancer Institute
Englewood, Colorado, United States
- Mountain Blue Cancer Care Center
Golden, Colorado, United States
- Rocky Mountain Cancer Centers-Lakewood
Lakewood, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Jun 2019
- Primary completion
- 31 Aug 2028
- Completion
- 31 Aug 2031
- Last update posted
- 18 Jun 2026
- Registered enrollment
- 40
- Registry id
- NCT03516279
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.